| JXSS2000048 | 迪妥昔单抗注射液 | dinutuximab | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2021-08-17 | view |
| CXHB2000072 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(原1.1) | Supplementary Application | 2020-08-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-08-19 | view |
| CXHB2100005 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-01-09 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2021-01-08 | view |
| CXHL1900248 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(1) | New Drug Application | 2019-08-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2019-08-19 | view |
| CXHB2000019 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-03-24 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-03-23 | view |
| CXHB2100057 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(原1.1) | Supplementary Application | 2021-04-10 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2022-01-27 | view |
| JYHB1800696 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2018-06-22 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-07-04 | view |
| JYHB2000714 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-06-05 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-06-16 | view |
| JYHB1901603 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-23 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-01-03 | view |
| JYHB1900013 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-01-28 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2019-08-28 | view |
| JYHB2001102 | 注射用阿扎胞苷 | azacitidine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-06-28 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-06-29 | view |
| JYSB2100061 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products(3.1) | Supplementary Application | 2021-02-26 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2022-01-27 | view |
| JXSS2100020 | 注射用贝林妥欧单抗 | blinatumomab | Lyophilized | Biological Products(3.1) | Import Drug Application | 2021-03-31 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2021-03-30 | view |
| JXHS1900069 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs(5.1) | Import Drug Application | 2019-06-03 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2021-02-02 | view |
| JYHB2000163 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2020-03-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-03-03 | view |
| JYHB1901550 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-14 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2019-12-23 | view |
| JYHB1801567 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2019-01-28 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2019-04-12 | view |
| JYHZ1800113 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | License Renew | 2018-04-27 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2018-09-30 | view |
| JYHB1901168 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2019-09-21 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2019-09-27 | view |
| JYHB1901432 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-07 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2020-01-02 | view |
